Resolution of foveal detachment in dome-shaped macula after treatment by spironolactone: report of two cases and mini-review of the literature.
Fiche du document
2014
- doi: 10.2147/OPTH.S62267
- issn: 1177-5467
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.2147/OPTH.S62267
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/24899797
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1177-5467
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_222D6FB3F9537
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
TherapyCiter ce document
A. Dirani et al., « Resolution of foveal detachment in dome-shaped macula after treatment by spironolactone: report of two cases and mini-review of the literature. », Serveur académique Lausannois, ID : 10.2147/OPTH.S62267
Métriques
Partage / Export
Résumé
Dome-shaped macula (DSM) was recently described in myopic patients as a convex protrusion of the macula within a posterior pole staphyloma. The pathogenesis of DSM and the development of associated serous foveal detachment (SFD) remain unclear. The obstruction of choroidal outflow and compressive changes of choroidal capillaries have been proposed as causative factors. In this paper, we report two cases of patients with chronic SFD associated with DSM treated with oral spironolactone. After treatment, there was a complete resolution of SFD in both patients. To the best of our knowledge, this is the first report of successful treatment of SFD in DSM by a mineralocorticoid receptor antagonist.